ClassID:

117434

C12Y306/04013 - CPC Classification

Classification description:

Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; involved in cellular and subcellular movement (3.6.4) RNA helicase (3.6.4.13)

Recent Application in this class:
#1
20260062692
2026-03-05

COMPOSITIONS AND METHODS FOR THE IMMOBILIZATION OF ENZYMES USING CROSSLINKED BIOMOLECULAR CONDENSATES

#2
20250215434
2025-07-03

COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING DDX54 INHIBITOR AND CANCER IMMUNOTHERAPY AGENT

#3
20250115886
2025-04-10

DESIGNER MEMBRANELESS ORGANELLES SEQUESTER NATIVE FACTORS FOR CONTROL OF CELL BEHAVIOR

#4
20240368568
2024-11-07

MODIFIED PRP43 HELICASE AND USE THEREOF

#5
20230314433
2023-10-05

METHOD OF DETERMINING VIRAL INFECTION

#6
20230016983
2023-01-19

ANTISENSE OLIGONUCLEOTIDES AND THIER USE FOR THE TREATMENT OF CANCER

#7
20210189388
2021-06-24

DNA-guided gene editing and regulation

#8
20210180133
2021-06-17

Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)

#9
20210179676
2021-06-17

FUSION PROTEIN AND NUCLEIC ACID MOLECULE FOR EXOGENOUS STIMULANT-DEPENDENT STRESS GRANULE ASSEMBLY

#10
20200224217
2020-07-16

Retinoic acid-inducible gene I promoter and compositions and methods relating to same

#11
20190330591
2019-10-31

AMPLIFIABLE RNAS FOR THERAPEUTIC CELL SYSTEMS

#12
20190127428
2019-05-02

Fusion protein and nucleic acid molecule for light-dependent stress granule assembly

#13
20190015498
2019-01-17

Immune enhancing recombinant dengue protein

#14
20180274033
2018-09-27

Method to identify subjects at higher risk to develop an autoimmune disease based on genetic and/or phenotypic screening for epistatic variants in DDX39B (RS2523506) and IL7R (RS6897932)

#15
20180243382
2018-08-30

TARGETING MDA-5 ACTIVATION FOR CANCER IMMUNOTHERAPY

#16
20180193430
2018-07-12

Compositions and methods to inhibit viral replication

#17
20180155445
2018-06-07

ANTI-VASA ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF

#18
20170166519
2017-06-15

Use of DDX3X inhibitors for the treatment of pneumovirus infections

#19
20170107299
2017-04-20

ANTI-VASA ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOF

#20
20170035875
2017-02-09

Immune enhancing recombinant dengue protein

#21
20160281053
2016-09-29

Polynucleotides encoding BREX system polypeptides and methods of using same

#22
20150297694
2015-10-22

CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS

#23
20150247151
2015-09-03

Cells and methods for producing rhamnolipids

#24
20150203888
2015-07-23

Capping prone RNA polymerase enzymes and their applications

#25
20150037342
2015-02-05

Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulin

#26
20130042334
2013-02-14

Capping-prone RNA polymerase enzymes and their applications

#27
20110305667
2011-12-15

USE OF A DEAD-BOX RNA HELICASE FOR INDUCING CYTOKINE PRODUCTION

#28
20110244485
2011-10-06

ANTI-TUNA VASA ANTIBODY

#29
18670452
2025-07-22

Conserved region T cell vaccines for coronavirus and methods of use

#30
17234590
2024-07-02

Conserved region T cell vaccines for coronavirus and methods of use